AKT1 and non-small cell lung carcinoma: It was observed that 18α-GA treated NSCLC cells showed significantly reduced expression of these targets indicating that NSCLC inhibition was mainly via the regulation of cell proliferation and survival through the EGFR- PI3K/Akt signaling pathways.